Th17 cytokines and host-pathogen interactions at the mucosa: Dichotomies of help and harm

Cytokine

Volumn 48, Issue 1-2, 2009, Pages 156-160

  Liu, Janet Z ^a,b   Pezeshki, Milad ^a,b   Raffatellu, Manuela ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Antimicrobial peptides; Mucosal immunity; Pathogenesis; Th17

Indexed keywords

BETA DEFENSIN; CHEMOKINE; CYTOKINE; INTERLEUKIN 17; INTERLEUKIN 17F; INTERLEUKIN 22; INTERLEUKIN 26; NEUTROPHIL GELATINASE ASSOCIATED LIPOCALIN; SIDEROPHORE;

BACTERIAL INFECTION; CANDIDA ALBICANS; CITROBACTER RODENTIUM; CYTOKINE RELEASE; HOST PATHOGEN INTERACTION; HUMAN; IMMUNE RESPONSE; INTESTINE INFECTION; KLEBSIELLA PNEUMONIAE; MICROBIAL COLONIZATION; MUCOSAL IMMUNITY; NONHUMAN; PERMEABILITY BARRIER; PRIORITY JOURNAL; PROTEIN FUNCTION; REVIEW; SALMONELLA TYPHIMURIUM; TH17 CELL;

ANIMALS; ANTIMICROBIAL CATIONIC PEPTIDES; BACTERIA; CHEMOKINES; CYTOKINES; HOST-PATHOGEN INTERACTIONS; HUMANS; IMMUNITY, MUCOSAL; INTERLEUKIN-17; INTERLEUKINS; MUCOUS MEMBRANE; T-LYMPHOCYTE SUBSETS; T-LYMPHOCYTES, HELPER-INDUCER;

CANDIDA ALBICANS; CITROBACTER RODENTIUM; KLEBSIELLA PNEUMONIAE; SALMONELLA TYPHIMURIUM;

EID: 70349113040     PISSN: 10434666     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cyto.2009.07.005     Document Type: Review

References (80)

1. Brenchley J.M., Price D.A., Schacker T.W., Asher T.E., Silvestri G., Rao S., et al. Microbial translocation is a cause of systemic immune activation in chronic HIV infection. Nat Med 12 (2006) 1365-1371
2. Bearman G.M., and Wenzel R.P. Bacteremias: a leading cause of death. Arch Med Res 36 (2005) 646-659
3. McBean M., and Rajamani S. Increasing rates of hospitalization due to septicemia in the US elderly population, 1986-1997. J Infect Dis 183 (2001) 596-603
4. Mogensen T.H. Pathogen recognition and inflammatory signaling in innate immune defenses. Clin Microbiol Rev 22 (2009) 240-273 table of contents
5. Franchi L., Eigenbrod T., Munoz-Planillo R., and Nunez G. The inflammasome: a caspase-1-activation platform that regulates immune responses and disease pathogenesis. Nat Immunol 10 (2009) 241-247
6. van Wijk F., and Cheroutre H. Intestinal T cells: facing the mucosal immune dilemma with synergy and diversity. Semin Immunol 21 (2009) 130-138
7. Brenchley J.M., Schacker T.W., Ruff L.E., Price D.A., Taylor J.H., Beilman G.J., et al. CD4+ T cell depletion during all stages of HIV disease occurs predominantly in the gastrointestinal tract. J Exp Med 200 (2004) 749-759
8. Guadalupe M., Reay E., Sankaran S., Prindiville T., Flamm J., McNeil A., et al. Severe CD4+ T-cell depletion in gut lymphoid tissue during primary human immunodeficiency virus type 1 infection and substantial delay in restoration following highly active antiretroviral therapy. J Virol 77 (2003) 11708-11717
9. Glaser J.B., Morton-Kute L., Berger S.R., Weber J., Siegal F.P., Lopez C., et al. Recurrent Salmonella typhimurium bacteremia associated with the acquired immunodeficiency syndrome. Ann Intern Med 102 (1985) 189-193
10. Gordon M.A. Salmonella infections in immunocompromised adults. J Infect 56 (2008) 413-422
11. Tee W., and Mijch A. Campylobacter jejuni bacteremia in human immunodeficiency virus (HIV)-infected and non-HIV-infected patients: comparison of clinical features and review. Clin Infect Dis 26 (1998) 91-96
12. Gautreaux M.D., Deitch E.A., and Berg R.D. T lymphocytes in host defense against bacterial translocation from the gastrointestinal tract. Infect Immun 62 (1994) 2874-2884
13. Gautreaux M.D., Gelder F.B., Deitch E.A., and Berg R.D. Adoptive transfer of T lymphocytes to T-cell-depleted mice inhibits Escherichia coli translocation from the gastrointestinal tract. Infect Immun 63 (1995) 3827-3834
14. Dubin P.J., and Kolls J.K. Th17 cytokines and mucosal immunity. Immunol Rev 226 (2008) 160-171
15. Harrington L.E., Hatton R.D., Mangan P.R., Turner H., Murphy T.L., Murphy K.M., et al. Interleukin 17-producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages. Nat Immunol 6 (2005) 1123-1132
16. Wilson N.J., Boniface K., Chan J.R., McKenzie B.S., Blumenschein W.M., Mattson J.D., et al. Development, cytokine profile and function of human interleukin 17-producing helper T cells. Nat Immunol 8 (2007) 950-957
17. Liang S.C., Tan X.Y., Luxenberg D.P., Karim R., Dunussi-Joannopoulos K., Collins M., et al. Interleukin (IL)-22 and IL-17 are coexpressed by Th17 cells and cooperatively enhance expression of antimicrobial peptides. J Exp Med 203 (2006) 2271-2279
18. Gaffen SL. Structure and signalling in the IL-17 receptor family. Nat Rev Immunol 2009, [Epub ahead of print].
19. Xie M.H., Aggarwal S., Ho W.H., Foster J., Zhang Z., Stinson J., et al. Interleukin (IL)-22, a novel human cytokine that signals through the interferon receptor-related proteins CRF2-4 and IL-22R. J Biol Chem 275 (2000) 31335-31339
20. Wolk K., Kunz S., Witte E., Friedrich M., Asadullah K., and Sabat R. IL-22 increases the innate immunity of tissues. Immunity 21 (2004) 241-254
21. Sheikh F., Baurin V.V., Lewis-Antes A., Shah N.K., Smirnov S.V., Anantha S., et al. Cutting edge: IL-26 signals through a novel receptor complex composed of IL-20 receptor 1 and IL-10 receptor 2. J Immunol 172 (2004) 2006-2010
22. Ye P., Rodriguez F.H., Kanaly S., Stocking K.L., Schurr J., Schwarzenberger P., et al. Requirement of interleukin 17 receptor signaling for lung CXC chemokine and granulocyte colony-stimulating factor expression, neutrophil recruitment, and host defense. J Exp Med 194 (2001) 519-527
23. Aujla S.J., Chan Y.R., Zheng M., Fei M., Askew D.J., Pociask D.A., et al. IL-22 mediates mucosal host defense against Gram-negative bacterial pneumonia. Nat Med 14 (2008) 275-281
24. Mangan P.R., Harrington L.E., O'Quinn D.B., Helms W.S., Bullard D.C., Elson C.O., et al. Transforming growth factor-beta induces development of the T(H)17 lineage. Nature 441 (2006) 231-234
25. Ishigame H., Kakuta S., Nagai T., Kadoki M., Nambu A., Komiyama Y., et al. Differential roles of interleukin-17A and -17F in host defense against mucoepithelial bacterial infection and allergic responses. Immunity 30 (2009) 108-119
26. Zheng Y., Valdez P.A., Danilenko D.M., Hu Y., Sa S.M., Gong Q., et al. Interleukin-22 mediates early host defense against attaching and effacing bacterial pathogens. Nat Med 14 (2008) 282-289
27. Raffatellu M., Chessa D., Wilson R.P., Dusold R., Rubino S., and Baumler A.J. The Vi capsular antigen of Salmonella enterica serotype Typhi reduces Toll-like receptor-dependent interleukin-8 expression in the intestinal mucosa. Infect Immun 73 (2005) 3367-3374
28. Raffatellu M., Santos R.L., Verhoeven D.E., George M.D., Wilson R.P., Winter S.E., et al. Simian immunodeficiency virus-induced mucosal interleukin-17 deficiency promotes Salmonella dissemination from the gut. Nat Med 14 (2008) 421-428
29. Conti H.R., Shen F., Nayyar N., Stocum E., Sun J.N., Lindemann M.J., et al. Th17 cells and IL-17 receptor signaling are essential for mucosal host defense against oral candidiasis. J Exp Med 206 (2009) 299-311
30. Awane M., Andres P.G., Li D.J., and Reinecker H.C. NF-kappa B-inducing kinase is a common mediator of IL-17-, TNF-alpha-, and IL-1 beta-induced chemokine promoter activation in intestinal epithelial cells. J Immunol 162 (1999) 5337-5344
31. Raffatellu M., George M.D., Akiyama Y., Hornsby M.J., Nuccio S.P., Paixao T.A., et al. Lipocalin-2 resistance confers an advantage to Salmonella enterica serotype Typhimurium for growth and survival in the inflamed intestine. Cell Host Microbe 5 (2009) 476-486
32. Andoh A., Zhang Z., Inatomi O., Fujino S., Deguchi Y., Araki Y., et al. Interleukin-22, a member of the IL-10 subfamily, induces inflammatory responses in colonic subepithelial myofibroblasts. Gastroenterology 129 (2005) 969-984
33. Chen Y., Thai P., Zhao Y.H., Ho Y.S., DeSouza M.M., and Wu R. Stimulation of airway mucin gene expression by interleukin (IL)-17 through IL-6 paracrine/autocrine loop. J Biol Chem 278 (2003) 17036-17043
34. Kao C.Y., Huang F., Chen Y., Thai P., Wachi S., Kim C., et al. Up-regulation of CC chemokine ligand 20 expression in human airway epithelium by IL-17 through a JAK-independent but MEK/NF-kappaB-dependent signaling pathway. J Immunol 175 (2005) 6676-6685
35. McAllister F., Henry A., Kreindler J.L., Dubin P.J., Ulrich L., Steele C., et al. Role of IL-17A, IL-17F, and the IL-17 receptor in regulating growth-related oncogene-alpha and granulocyte colony-stimulating factor in bronchial epithelium: implications for airway inflammation in cystic fibrosis. J Immunol 175 (2005) 404-412
36. Ziesche E., Bachmann M., Kleinert H., Pfeilschifter J., and Muhl H. The interleukin-22/STAT3 pathway potentiates expression of inducible nitric-oxide synthase in human colon carcinoma cells. J Biol Chem 282 (2007) 16006-16015
37. Cai X.Y., Gommoll Jr. C.P., Justice L., Narula S.K., and Fine J.S. Regulation of granulocyte colony-stimulating factor gene expression by interleukin-17. Immunol Lett 62 (1998) 51-58
38. Numasaki M., Takahashi H., Tomioka Y., and Sasaki H. Regulatory roles of IL-17 and IL-17F in G-CSF production by lung microvascular endothelial cells stimulated with IL-1beta and/or TNF-alpha. Immunol Lett 95 (2004) 97-104
39. Kuritzkes D.R. Neutropenia, neutrophil dysfunction, and bacterial infection in patients with human immunodeficiency virus disease: the role of granulocyte colony-stimulating factor. Clin Infect Dis 30 (2000) 256-260
40. Pitrak D.L. Neutrophil deficiency and dysfunction in HIV-infected patients. Am J Health Syst Pharm 56 Suppl. 5 (1999) S9-S16
41. Brandl K., Plitas G., Mihu C.N., Ubeda C., Jia T., Fleisher M., et al. Vancomycin-resistant enterococci exploit antibiotic-induced innate immune deficits. Nature 455 (2008) 804-807
42. Godinez I., Raffatellu M., Chu H., Paixao T.A., Haneda T., Santos R.L., et al. Interleukin-23 orchestrates mucosal responses to Salmonella enterica serotype Typhimurium in the intestine. Infect Immun 77 (2009) 387-398
43. Cash H.L., Whitham C.V., Behrendt C.L., and Hooper L.V. Symbiotic bacteria direct expression of an intestinal bactericidal lectin. Science 313 (2006) 1126-1130
44. Diamond G., and Bevins C.L. Beta-defensins: endogenous antibiotics of the innate host defense response. Clin Immunol Immunopathol 88 (1998) 221-225
45. Vylkova S., Li X.S., Berner J.C., and Edgerton M. Distinct antifungal mechanisms: beta-defensins require Candida albicans Ssa1 protein, while Trk1p mediates activity of cysteine-free cationic peptides. Antimicrob Agents Chemother 50 (2006) 324-331
46. Pedron T., and Sansonetti P. Commensals, bacterial pathogens and intestinal inflammation: an intriguing menage a trois. Cell Host Microbe 3 (2008) 344-347
47. Lupp C., Robertson M.L., Wickham M.E., Sekirov I., Champion O.L., Gaynor E.C., et al. Host-mediated inflammation disrupts the intestinal microbiota and promotes the overgrowth of Enterobacteriaceae. Cell Host Microbe 2 (2007) 204
48. Stecher B., Robbiani R., Walker A.W., Westendorf A.M., Barthel M., Kremer M., et al. Salmonella enterica serovar typhimurium exploits inflammation to compete with the intestinal microbiota. PLoS Biol 5 (2007) 2177-2189
49. Barman M., Unold D., Shifley K., Amir E., Hung K., Bos N., et al. Enteric salmonellosis disrupts the microbial ecology of the murine gastrointestinal tract. Infect Immun 76 (2008) 907-915
50. Lawley T.D., Bouley D.M., Hoy Y.E., Gerke C., Relman D.A., and Monack D.M. Host transmission of Salmonella enterica serovar Typhimurium is controlled by virulence factors and indigenous intestinal microbiota. Infect Immun 76 (2008) 403-416
51. Stecher B., Barthel M., Schlumberger M.C., Haberli L., Rabsch W., Kremer M., et al. Motility allows S. typhimurium to benefit from the mucosal defence. Cell Microbiol 10 (2008) 1166-1180
52. Henderson I.R., Czeczulin J., Eslava C., Noriega F., and Nataro J.P. Characterization of pic, a secreted protease of Shigella flexneri and enteroaggregative Escherichia coli. Infect Immun 67 (1999) 5587-5596
53. Harrington S.M., Sheikh J., Henderson I.R., Ruiz-Perez F., Cohen P.S., and Nataro J.P. The Pic protease of enteroaggregative Escherichia coli promotes intestinal colonization and growth in the presence of mucin. Infect Immun 77 (2009) 2465-2473
54. Ong S.T., Ho J.Z., Ho B., and Ding J.L. Iron-withholding strategy in innate immunity. Immunobiology 211 (2006) 295-314
55. Braun V., Hantke K., and Koster W. Bacterial iron transport: mechanisms, genetics, and regulation. Met Ions Biol Syst 35 (1998) 67-145
56. Ratledge C. Iron metabolism and infection. Food Nutr Bull 28 (2007) S515-S523
57. Flo T.H., Smith K.D., Sato S., Rodriguez D.J., Holmes M.A., Strong R.K., et al. Lipocalin 2 mediates an innate immune response to bacterial infection by sequestrating iron. Nature 432 (2004) 917-921
58. Khashe S., and Janda J.M. Iron utilization studies in Citrobacter species. FEMS Microbiol Lett 137 (1996) 141-146
59. Braun V. Iron uptake by Escherichia coli. Front Biosci 8 (2003) s1409-s1421
60. Kingsley R., Rabsch W., Stephens P., Roberts M., Reissbrodt R., and Williams P.H. Iron supplying systems of Salmonella in diagnostics, epidemiology and infection. FEMS Immunol Med Microbiol 11 (1995) 257-264
61. Podschun R., Fischer A., and Ullmann U. Siderophore production of Klebsiella species isolated from different sources. Zentralbl Bakteriol 276 (1992) 481-486
62. Berger T., Togawa A., Duncan G.S., Elia A.J., You-Ten A., Wakeham A., et al. Lipocalin 2-deficient mice exhibit increased sensitivity to Escherichia coli infection but not to ischemia-reperfusion injury. Proc Natl Acad Sci USA 103 (2006) 1834-1839
63. Crosa J.H. Genetics and molecular biology of siderophore-mediated iron transport in bacteria. Microbiol Rev 53 (1989) 517-530
64. Baumler A.J., Tsolis R.M., van der Velden A.W., Stojiljkovic I., Anic S., and Heffron F. Identification of a new iron regulated locus of Salmonella typhi. Gene 183 (1996) 207-213
65. Fischbach M.A., Lin H., Zhou L., Yu Y., Abergel R.J., Liu D.R., et al. The pathogen-associated iroA gene cluster mediates bacterial evasion of lipocalin 2. Proc Natl Acad Sci USA 103 (2006) 16502-16507
66. Bister B., Bischoff D., Nicholson G.J., Valdebenito M., Schneider K., Winkelmann G., et al. The structure of salmochelins: C-glucosylated enterobactins of Salmonella enterica. Biometals 17 (2004) 471-481
67. Hantke K., Nicholson G., Rabsch W., and Winkelmann G. Salmochelins, siderophores of Salmonella enterica and uropathogenic Escherichia coli strains, are recognized by the outer membrane receptor IroN. Proc Natl Acad Sci USA 100 (2003) 3677-3682
68. Fischbach M.A., Lin H., Liu D.R., and Walsh C.T. How pathogenic bacteria evade mammalian sabotage in the battle for iron. Nat Chem Biol 2 (2006) 132-138
69. Crouch M.L., Castor M., Karlinsey J.E., Kalhorn T., and Fang F.C. Biosynthesis and IroC-dependent export of the siderophore salmochelin are essential for virulence of Salmonella enterica serovar Typhimurium. Mol Microbiol 67 (2008) 971-983
70. Caza M., Lepine F., Milot S., and Dozois C.M. Specific roles of the iroBCDEN genes in virulence of an avian pathogenic Escherichia coli O78 strain and in production of salmochelins. Infect Immun 76 (2008) 3539-3549
71. Chan Y.R., Liu J.S., Pociask D.A., Zheng M., Mietzner T.A., Berger T., et al. Lipocalin 2 is required for pulmonary host defense against Klebsiella infection. J Immunol 182 (2009) 4947-4956
72. Lawlor M.S., O'Connor C., and Miller V.L. Yersiniabactin is a virulence factor for Klebsiella pneumoniae during pulmonary infection. Infect Immun 75 (2007) 1463-1472
73. Valdebenito M., Crumbliss A.L., Winkelmann G., and Hantke K. Environmental factors influence the production of enterobactin, salmochelin, aerobactin, and yersiniabactin in Escherichia coli strain Nissle 1917. Int J Med Microbiol 296 (2006) 513-520
74. Nelson A.L., Barasch J.M., Bunte R.M., and Weiser J.N. Bacterial colonization of nasal mucosa induces expression of siderocalin, an iron-sequestering component of innate immunity. Cell Microbiol 7 (2005) 1404-1417
75. Hornsby M.J., Huff J.L., Kays R.J., Canfield D.R., Bevins C.L., and Solnick J.V. Helicobacter pylori induces an antimicrobial response in rhesus macaques in a cag pathogenicity island-dependent manner. Gastroenterology 134 (2008) 1049-1057
76. Corbin B.D., Seeley E.H., Raab A., Feldmann J., Miller M.R., Torres V.J., et al. Metal chelation and inhibition of bacterial growth in tissue abscesses. Science 319 (2008) 962-965
77. Abraham C., and Cho J.H. IL-23 and autoimmunity: new insights into the pathogenesis of inflammatory bowel disease. Annu Rev Med 60 (2008) 97-110
78. Louten J., Boniface K., and de Waal Malefyt R. Development and function of TH17 cells in health and disease. J Allergy Clin Immunol 123 (2009) 1004-1011
79. Korn T. Pathophysiology of multiple sclerosis. J Neurol 255 Suppl 6 (2008) 2-6
80. Fouser L.A., Wright J.F., Dunussi-Joannopoulos K., and Collins M. Th17 cytokines and their emerging roles in inflammation and autoimmunity. Immunol Rev 226 (2008) 87-102